Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1Phase 3 1Phase 1 1

Status

Completed 4Withdrawn 1

Sponsor Class

OTHER 5NIH 3NETWORK 1INDUSTRY 1

Study Type

Interventional 5Observational 1

Sponsor

Cancer Type

Gynecologic 2

Conditions

Warts 1Uterine Cervical Neoplasms 1Squamous Intraepithelial Lesions 1High-grade Anal Intraepithelial Neoplasia 1HIV 1

Interventions

Cyclophosphamide 2042Radiotherapy 1859Cisplatin 1825Carboplatin 1533Gemcitabine 1434Paclitaxel 1289Bevacizumab 1270Docetaxel 1202pembrolizumab 1199Oxaliplatin 1160Capecitabine 1144Fluorouracil 1061Dexamethasone 971Rituximab 919Nivolumab 908Magnetic Resonance Spectroscopy 862Etoposide 839Doxorubicin 823Drug Therapy 792Radiosurgery 776Irinotecan 775Cytarabine 736fludarabine 716Leucovorin 676Lenalidomide 608fludarabine phosphate 564Temozolomide 552Radiation 541Filgrastim 540Cetuximab 537

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
OTHER × Interventional × Cidofovir × Clear all
NCT04055142 2024-07-10

TreatAIN

Hospital Universitari Vall d'Hebron Research Institute

Phase 3 Completed
108 enrolled

High-grade Anal Intraepithelial Neoplasia

NCT02567149 2017-07-02

Intralesional Cidofovir for the Treatment of Recalcitrant Warts in the Pediatric Immune-suppressed Population.

University of Minnesota

Phase 2 Withdrawn

Warts

NCT02976987 2016-11-30

A Prolongation of a Clinical Study to Evaluate the Efficacy of an Aqueous Gel Containing 2% (w/w) of Cidofovir, Directly Applied on the Cervix Exhibiting High Grade Squamous Intraepithelial Lesions.

Brugmann University Hospital

Phase 2 Completed
36 enrolled
Gynecologic

Squamous Intraepithelial Lesions

NCT01946009 2016-06-29

CIDAN12

Fundacion SEIMC-GESIDA

Phase NA Completed
20 enrolled

HIV

NCT02515877 2016-06-09

HPV-RX

Gustave Roussy, Cancer Campus, Grand Paris

Phase 1 Completed
15 enrolled
Gynecologic

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡